DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN

DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN was reported 4895 times

DEXTROMETHORPHAN HYDROBROMIDE AND GUAIFENESIN is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 BONE MARROW HARVEST FAILURE 1 0.2000
1 ARTERIOGRAM CAROTID ABNORMAL 1 0.1111
2 HERPES SIMPLEX VIRAEMIA 2 0.0160
3 BACTEROIDES TEST POSITIVE 1 0.0152
4 FAILURE OF CHILD RESISTANT PRODUCT CLOSURE 2 0.0145
5 CESTODE INFECTION 1 0.0137
6 ANTICOAGULATION DRUG LEVEL ABNORMAL 2 0.0134
7 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 89 0.0131
8 POST-TUSSIVE VOMITING 2 0.0123
9 CENTRAL NERVOUS SYSTEM STIMULATION 2 0.0113
10 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 81 0.0113
11 ATYPICAL MYCOBACTERIUM TEST POSITIVE 1 0.0103
12 ACCIDENTAL OVERDOSE 333 0.0091
13 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 54 0.0089
14 BURKHOLDERIA TEST POSITIVE 1 0.0081
15 AUTOSCOPY 4 0.0074
16 AORTIC ATHEROSCLEROSIS 1 0.0068
17 ENTEROBACTER BACTERAEMIA 2 0.0066
18 GASTROINTESTINAL MUCOSAL DISORDER 4 0.0061
19 ANAL SKIN TAGS 1 0.0061
20 OXYGEN SATURATION INCREASED 2 0.0059
21 FEELING DRUNK 43 0.0058
22 THERAPEUTIC PRODUCT EFFECTIVE FOR UNAPPROVED INDICATION 2 0.0054
23 CHRONIC GRAFT VERSUS HOST DISEASE IN INTESTINE 1 0.0053
24 FAILURE OF CHILD RESISTANT MECHANISM FOR PHARMACEUTICAL PRODUCT 2 0.0046
25 BENDOPNOEA 1 0.0045
26 THERAPEUTIC PRODUCT INEFFECTIVE FOR UNAPPROVED INDICATION 2 0.0044
27 LOCKED-IN SYNDROME 2 0.0043
28 CEREBRAL NOCARDIOSIS 1 0.0043
29 BREATHING-RELATED SLEEP DISORDER 1 0.0042
30 BENIGN LUNG NEOPLASM 1 0.0040
31 CONTRAINDICATION TO MEDICAL TREATMENT 6 0.0039
32 LOWER RESPIRATORY TRACT INFECTION BACTERIAL 2 0.0039
33 MYDRIASIS 50 0.0039
34 ALVEOLITIS ALLERGIC 4 0.0039
35 PRESBYOPIA 2 0.0036
36 BRONCHOSPASM PARADOXICAL 1 0.0033
37 CHANGE IN SUSTAINED ATTENTION 1 0.0033
38 EUPHORIC MOOD 34 0.0033
39 ACCIDENTAL DRUG INTAKE BY CHILD 5 0.0033
40 IMMUNE RECONSTITUTION SYNDROME 4 0.0031
41 SLOW RESPONSE TO STIMULI 4 0.0031
42 ALLERGIC RESPIRATORY SYMPTOM 1 0.0030
43 PRODUCT DIFFICULT TO SWALLOW 3 0.0030
44 EYE ROLLING 2 0.0028
45 CATHETER REMOVAL 1 0.0028
46 GRAFT VERSUS HOST DISEASE IN LIVER 2 0.0028
47 SYSTEMIC SCLERODERMA 2 0.0027
48 GENERALISED ANXIETY DISORDER 4 0.0027
49 BIOPSY LUNG 1 0.0027
50 INAPPROPRIATE AFFECT 4 0.0025
51 BRONCHITIS ACUTE 1 0.0025
52 REACTION TO PRESERVATIVES 2 0.0025
53 ALLERGY TO PLANTS 1 0.0022
54 INFUSION SITE RASH 3 0.0022
55 PHARYNGEAL HYPOAESTHESIA 2 0.0022
56 PSYCHOGENIC SEIZURE 2 0.0021
57 BIOPSY BONE MARROW 1 0.0021
58 HYPERVIGILANCE 2 0.0021
59 OVERDOSE 431 0.0020
60 BREAST CONSERVING SURGERY 1 0.0020
61 PSYCHOMOTOR HYPERACTIVITY 32 0.0019
62 EXPIRED PRODUCT ADMINISTERED 61 0.0018
63 PRODUCT LOT NUMBER ISSUE 4 0.0018
64 AORTIC DILATATION 2 0.0018
65 PRODUCT TASTE ABNORMAL 24 0.0018
66 INCORRECT DRUG ADMINISTRATION DURATION 47 0.0017
67 STARING 4 0.0017
68 BLOOD VISCOSITY INCREASED 1 0.0017
69 ESSENTIAL HYPERTENSION 3 0.0016
70 ALLERGY TO CHEMICALS 2 0.0016
71 RENAL ATROPHY 2 0.0016
72 THERAPEUTIC PRODUCT INEFFECTIVE 6 0.0016
73 CARDIAC VENTRICULAR THROMBOSIS 2 0.0015
74 CHONDROCALCINOSIS 1 0.0015
75 PRODUCT FORMULATION ISSUE 10 0.0015
76 OESOPHAGEAL CANDIDIASIS 6 0.0015
77 MACULAR HOLE 2 0.0015
78 PRODUCT SIZE ISSUE 8 0.0015
79 EAR HAEMORRHAGE 3 0.0015
80 PRODUCT LABEL ISSUE 10 0.0015
81 DRUG ABUSER 9 0.0015
82 PRODUCT EXPIRATION DATE ISSUE 2 0.0014
83 H1N1 INFLUENZA 2 0.0014
84 CATAPLEXY 2 0.0014
85 TRACHEOSTOMY 2 0.0014
86 HYPERTONIC BLADDER 4 0.0014
87 INCORRECT PRODUCT ADMINISTRATION DURATION 30 0.0014
88 BITE 1 0.0014
89 ATROPHIC VULVOVAGINITIS 1 0.0014
90 BENIGN NEOPLASM OF THYROID GLAND 1 0.0014
91 GENITAL PAIN 2 0.0014
92 PRODUCT PACKAGE ASSOCIATED INJURY 3 0.0013
93 GASTROINTESTINAL WALL THICKENING 2 0.0013
94 LICHENOID KERATOSIS 3 0.0013
95 NO ADVERSE EVENT 238 0.0013
96 HALLUCINATION 98 0.0013
97 ALLERGIC COUGH 1 0.0013
98 BLISTER INFECTED 1 0.0013
99 CHOKING SENSATION 7 0.0013
100 PRODUCT COMPLAINT 32 0.0013
101 VIRAL UPPER RESPIRATORY TRACT INFECTION 6 0.0013
102 PHARYNGEAL PARAESTHESIA 2 0.0013
103 STUPOR 4 0.0012
104 CYSTITIS INTERSTITIAL 2 0.0012
105 ALTERED VISUAL DEPTH PERCEPTION 1 0.0012
106 ACNE PUSTULAR 1 0.0012
107 SELF-MEDICATION 5 0.0012
108 ANAEMIA HAEMOLYTIC AUTOIMMUNE 1 0.0012
109 ADRENAL MASS 1 0.0012
110 SLEEP TALKING 2 0.0012
111 ACUTE SINUSITIS 2 0.0012
112 FAILURE TO THRIVE 6 0.0012
113 PUPIL FIXED 2 0.0012
114 INFUSION SITE DISCHARGE 2 0.0011
115 VOCAL CORD PARALYSIS 2 0.0011
116 FACIAL BONES FRACTURE 4 0.0011
117 BONE CONTUSION 1 0.0011
118 BONE GRAFT 1 0.0011
119 HYPERTENSIVE HEART DISEASE 2 0.0011
120 HYPOAESTHESIA ORAL 16 0.0011
121 SEASONAL ALLERGY 15 0.0011
122 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 31 0.0011
123 BRAIN STEM HAEMORRHAGE 1 0.0011
124 FEELING JITTERY 20 0.0010
125 CANCER SURGERY 1 0.0010
126 HALLUCINATION, VISUAL 22 0.0010
127 HEPATIC MASS 2 0.0010
128 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
129 DRUG ABUSE 86 0.0010
130 CONVERSION DISORDER 2 0.0010
131 ANIMAL SCRATCH 1 0.0010
132 ANTISOCIAL BEHAVIOUR 1 0.0010
133 EJACULATION FAILURE 2 0.0010
134 FOAMING AT MOUTH 2 0.0010
135 AXILLARY MASS 1 0.0010
136 DRUG INEFFECTIVE 1262 0.0010
137 PNEUMONIA VIRAL 3 0.0009
138 ALLERGY TO ANIMAL 1 0.0009
139 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 66 0.0009
140 REACTION TO DRUG EXCIPIENTS 2 0.0009
141 BIPOLAR I DISORDER 2 0.0009
142 DISORIENTATION 36 0.0009
143 COUGH 252 0.0009
144 PNEUMOCYSTIS JIROVECI PNEUMONIA 2 0.0009
145 SUBSTANCE-INDUCED PSYCHOTIC DISORDER 2 0.0009
146 DRY THROAT 9 0.0009
147 EYE MOVEMENT DISORDER 6 0.0009
148 ARTERIAL HAEMORRHAGE 1 0.0009
149 RESPIRATORY TRACT INFECTION VIRAL 2 0.0009
150 HANGOVER 3 0.0009
151 INGROWING NAIL 2 0.0008
152 RETCHING 18 0.0008
153 MYOPIA 2 0.0008
154 SOMNOLENCE 169 0.0008
155 URINARY HESITATION 2 0.0008
156 OXYGEN CONSUMPTION INCREASED 2 0.0008
157 BRONCHIAL HYPERREACTIVITY 1 0.0008
158 SCLERODERMA 3 0.0008
159 BRONCHITIS CHRONIC 2 0.0008
160 BLADDER PROLAPSE 1 0.0008
161 HAEMATOLOGICAL INFECTION 2 0.0008
162 SUFFOCATION FEELING 2 0.0008
163 NASAL DRYNESS 5 0.0008
164 EXPOSURE VIA INGESTION 2 0.0008
165 DIZZINESS 395 0.0008
166 BRONCHIAL SECRETION RETENTION 1 0.0008
167 CALCIUM DEFICIENCY 1 0.0008
168 ADJUSTMENT DISORDER 1 0.0008
169 PRODUCT PACKAGING DIFFICULT TO OPEN 2 0.0008
170 SOMNAMBULISM 5 0.0008
171 FOREIGN BODY 3 0.0007
172 TEMPOROMANDIBULAR JOINT SYNDROME 2 0.0007
173 ABDOMINAL MASS 2 0.0007
174 DYSARTHRIA 28 0.0007
175 BODY MASS INDEX INCREASED 1 0.0007
176 CHEILITIS 4 0.0007
177 EAR CONGESTION 2 0.0007
178 SPUTUM DISCOLOURED 7 0.0007
179 B-LYMPHOCYTE COUNT DECREASED 1 0.0007
180 CARBON DIOXIDE INCREASED 1 0.0007
181 PRODUCTIVE COUGH 35 0.0007
182 FEELING ABNORMAL 174 0.0007
183 PLEURITIC PAIN 2 0.0007
184 DROOLING 5 0.0007
185 STREPTOCOCCAL INFECTION 4 0.0007
186 CHROMATURIA 16 0.0007
187 ABNORMAL BEHAVIOUR 28 0.0007
188 AUDITORY DISORDER 1 0.0007
189 CARDIAC FAILURE CHRONIC 3 0.0007
190 PRODUCT USE COMPLAINT 11 0.0007
191 LIP PAIN 2 0.0007
192 CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY 1 0.0007
193 NERVOUSNESS 36 0.0007
194 LIQUID PRODUCT PHYSICAL ISSUE 5 0.0007
195 PULMONARY PAIN 2 0.0007
196 MAJOR DEPRESSION 5 0.0007
197 CARDIAC FIBRILLATION 1 0.0007
198 ENERGY INCREASED 4 0.0007
199 RESPIRATORY RATE INCREASED 6 0.0007
200 CHOLANGIOCARCINOMA 1 0.0007
201 ADHESION 1 0.0007
202 REBOUND ACID HYPERSECRETION 2 0.0007
203 EMERGENCY CARE 2 0.0007
204 DIASTOLIC DYSFUNCTION 2 0.0006
205 INFUSION SITE SWELLING 4 0.0006
206 INFUSION SITE PRURITUS 2 0.0006
207 RESPIRATORY TRACT CONGESTION 10 0.0006
208 INTENTIONAL OVERDOSE 40 0.0006
209 VITAMIN D DEFICIENCY 6 0.0006
210 CHOKING 12 0.0006
211 INJECTION SITE INFECTION 2 0.0006
212 INSOMNIA 162 0.0006
213 INFUSION SITE HAEMORRHAGE 2 0.0006
214 HEPATIC ENZYME ABNORMAL 3 0.0006
215 CHOLECYSTITIS CHRONIC 4 0.0006
216 SINUS CONGESTION 8 0.0006
217 ATAXIA 7 0.0006
218 INCREASED UPPER AIRWAY SECRETION 3 0.0006
219 REGURGITATION 2 0.0006
220 PARANOIA 10 0.0006
221 DELUSION 9 0.0006
222 FUNCTIONAL GASTROINTESTINAL DISORDER 2 0.0006
223 IMMUNOSUPPRESSION 5 0.0006
224 NYSTAGMUS 3 0.0006
225 LUNG TRANSPLANT 2 0.0006
226 DIARRHOEA 363 0.0006
227 FOOD POISONING 3 0.0006
228 INJECTION SITE DISCHARGE 3 0.0006
229 PARAESTHESIA ORAL 8 0.0006
230 FAECES DISCOLOURED 12 0.0006
231 UNRESPONSIVE TO STIMULI 14 0.0005
232 HIATUS HERNIA 7 0.0005
233 LIP SWELLING 18 0.0005
234 HEART RATE ABNORMAL 3 0.0005
235 HAEMOPTYSIS 15 0.0005
236 HYPERACUSIS 2 0.0005
237 HEART RATE INCREASED 53 0.0005
238 THROAT IRRITATION 24 0.0005
239 CHRONIC SINUSITIS 2 0.0005
240 PHOTOPHOBIA 10 0.0005
241 SNORING 2 0.0005
242 CONTRAINDICATED PRODUCT ADMINISTERED 16 0.0005
243 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 95 0.0005
244 FACE INJURY 2 0.0005
245 ARTERIAL DISORDER 1 0.0005
246 GASTRIC INFECTION 2 0.0005
247 THROAT TIGHTNESS 14 0.0005
248 ARTERIAL THROMBOSIS 1 0.0005
249 SKIN WARM 3 0.0005
250 ABDOMINAL WALL HAEMATOMA 1 0.0005
251 FEELING OF BODY TEMPERATURE CHANGE 3 0.0005
252 COLD SWEAT 9 0.0005
253 BLOOD PRESSURE INCREASED 78 0.0005
254 HEAD DISCOMFORT 9 0.0005
255 PNEUMONIA FUNGAL 2 0.0005
256 SINUS DISORDER 10 0.0005
257 CELL DEATH 1 0.0005
258 APHONIA 7 0.0005
259 DIPLOPIA 13 0.0005
260 GASTROENTERITIS VIRAL 9 0.0005
261 ENURESIS 2 0.0005
262 NOCTURIA 6 0.0005
263 INITIAL INSOMNIA 5 0.0005
264 LETHARGY 28 0.0005
265 ANOSMIA 7 0.0005
266 CHEST INJURY 1 0.0005
267 ADJUSTMENT DISORDER WITH DEPRESSED MOOD 1 0.0005
268 EYE DISCHARGE 5 0.0005
269 PULMONARY HYPERTENSION 10 0.0005
270 ATRIAL TACHYCARDIA 1 0.0005
271 SLEEP TERROR 2 0.0005
272 ABDOMINAL PAIN UPPER 97 0.0005
273 SCREAMING 3 0.0005
274 EXTRA DOSE ADMINISTERED 19 0.0005
275 PURULENT DISCHARGE 2 0.0005
276 MENTAL STATUS CHANGES 13 0.0005
277 PRODUCT CONTAINER ISSUE 4 0.0005
278 RESTLESSNESS 17 0.0005
279 CARDIAC FLUTTER 3 0.0005
280 INCOHERENT 3 0.0005
281 OCULAR ICTERUS 2 0.0005
282 POLYP 3 0.0005
283 HAEMORRHAGIC ANAEMIA 2 0.0005
284 RHINITIS ALLERGIC 2 0.0004
285 BRAIN FOG 7 0.0004
286 DYSSTASIA 13 0.0004
287 IRON DEFICIENCY 2 0.0004
288 WRONG PRODUCT ADMINISTERED 3 0.0004
289 CHRONIC GASTRITIS 1 0.0004
290 MICTURITION URGENCY 5 0.0004
291 PNEUMONIA BACTERIAL 4 0.0004
292 RESPIRATION ABNORMAL 3 0.0004
293 INCREASED TENDENCY TO BRUISE 4 0.0004
294 SYNOVIAL CYST 2 0.0004
295 BREAKTHROUGH PAIN 1 0.0004
296 NEPHROGENIC ANAEMIA 2 0.0004
297 INTERCEPTED MEDICATION ERROR 2 0.0004
298 RENAL FUNCTION TEST ABNORMAL 2 0.0004
299 BILIRUBIN CONJUGATED INCREASED 1 0.0004
300 CONFUSIONAL STATE 69 0.0004
301 TUBULOINTERSTITIAL NEPHRITIS 8 0.0004
302 HYPOXIA 15 0.0004
303 EYE DISORDER 14 0.0004
304 MANIA 7 0.0004
305 SKIN TIGHTNESS 2 0.0004
306 PRODUCT PACKAGING ISSUE 4 0.0004
307 SLEEP APNOEA SYNDROME 8 0.0004
308 FAECAL INCONTINENCE 2 0.0004
309 FINGER DEFORMITY 2 0.0004
310 BREATH ODOUR 1 0.0004
311 UNEVALUABLE EVENT 31 0.0004
312 INCORRECT DOSAGE ADMINISTERED 2 0.0004
313 RENAL CELL CARCINOMA 2 0.0004
314 PALLOR 11 0.0004
315 GASTROINTESTINAL SOUNDS ABNORMAL 2 0.0004
316 HYPERNATRAEMIA 2 0.0004
317 HYDRONEPHROSIS 3 0.0004
318 DRUG TOLERANCE 2 0.0004
319 FEELING COLD 11 0.0004
320 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 2 0.0004
321 TREMOR 65 0.0004
322 DISSOCIATION 3 0.0004
323 ACUTE LYMPHOCYTIC LEUKAEMIA RECURRENT 1 0.0004
324 BRONCHOPULMONARY ASPERGILLOSIS 3 0.0004
325 VISION BLURRED 53 0.0004
326 CATHETER SITE PAIN 1 0.0004
327 ACTINIC KERATOSIS 1 0.0004
328 RESPIRATORY TRACT INFECTION 10 0.0004
329 MULTIPLE ALLERGIES 3 0.0004
330 PRODUCT ADMINISTRATION INTERRUPTED 3 0.0004
331 PULMONARY CONGESTION 5 0.0004
332 FURUNCLE 3 0.0004
333 EYE SWELLING 14 0.0004
334 THINKING ABNORMAL 7 0.0004
335 BLOOD POTASSIUM ABNORMAL 1 0.0004
336 ALCOHOL POISONING 1 0.0004
337 BREAST SWELLING 1 0.0004
338 DYSPNOEA EXERTIONAL 14 0.0004
339 URINARY INCONTINENCE 11 0.0004
340 GINGIVITIS 2 0.0004
341 BLOOD SODIUM INCREASED 1 0.0004
342 STRESS FRACTURE 2 0.0004
343 MUSCLE DISORDER 3 0.0004
344 PRESYNCOPE 9 0.0004
345 ABDOMINAL RIGIDITY 1 0.0004
346 ANORGASMIA 1 0.0004
347 DECUBITUS ULCER 3 0.0004
348 BIPOLAR DISORDER 4 0.0004
349 AGITATION 27 0.0004
350 POLYURIA 3 0.0004
351 BLOOD PHOSPHORUS INCREASED 1 0.0004
352 ABNORMAL FAECES 3 0.0004
353 HYPERHIDROSIS 47 0.0004
354 BRONCHITIS 27 0.0004
355 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 20 0.0004
356 ABDOMINAL DISCOMFORT 61 0.0004
357 HYPOMAGNESAEMIA 5 0.0004
358 DYSPHONIA 21 0.0004
359 FEELING HOT 22 0.0004
360 BALANCE DISORDER 31 0.0004
361 OCULAR DISCOMFORT 4 0.0004
362 INFUSION SITE ERYTHEMA 3 0.0004
363 EYE INFECTION 4 0.0004
364 HEART RATE IRREGULAR 8 0.0004
365 SWOLLEN TONGUE 11 0.0004
366 IMPAIRED DRIVING ABILITY 4 0.0004
367 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 25 0.0004
368 MOUTH SWELLING 2 0.0003
369 UPPER RESPIRATORY TRACT INFECTION 16 0.0003
370 URTICARIA 58 0.0003
371 HYPERVENTILATION 2 0.0003
372 METABOLIC DISORDER 2 0.0003
373 BLOOD PARATHYROID HORMONE INCREASED 1 0.0003
374 PRODUCT LABEL CONFUSION 2 0.0003
375 AUTONOMIC NERVOUS SYSTEM IMBALANCE 1 0.0003
376 HYPOVOLAEMIA 2 0.0003
377 PALPITATIONS 40 0.0003
378 NASAL CONGESTION 20 0.0003
379 BRADYKINESIA 2 0.0003
380 BACTERAEMIA 4 0.0003
381 PLEURISY 2 0.0003
382 FACIAL PAIN 3 0.0003
383 IMMUNODEFICIENCY 5 0.0003
384 ATYPICAL PNEUMONIA 1 0.0003
385 ANXIETY 95 0.0003
386 DRY MOUTH 27 0.0003
387 TOOTHACHE 6 0.0003
388 INJECTION SITE VESICLES 2 0.0003
389 RESTLESS LEGS SYNDROME 6 0.0003
390 BURSITIS 4 0.0003
391 URINARY RETENTION 11 0.0003
392 INGUINAL HERNIA 2 0.0003
393 HYPERSENSITIVITY 61 0.0003
394 TENSION 2 0.0003
395 INSURANCE ISSUE 5 0.0003
396 RESPIRATORY DISTRESS 9 0.0003
397 ABNORMAL DREAMS 9 0.0003
398 MENISCUS INJURY 2 0.0003
399 POOR QUALITY SLEEP 7 0.0003
400 PHARYNGEAL OEDEMA 5 0.0003
401 RHINORRHOEA 21 0.0003
402 AGEUSIA 8 0.0003
403 PRE-EXISTING CONDITION IMPROVED 2 0.0003
404 INTERVERTEBRAL DISC PROTRUSION 7 0.0003
405 NASOPHARYNGITIS 59 0.0003
406 BLOOD BLISTER 1 0.0003
407 LOSS OF CONSCIOUSNESS 41 0.0003
408 DYSKINESIA 13 0.0003
409 SECRETION DISCHARGE 4 0.0003
410 BLOOD CREATININE DECREASED 1 0.0003
411 POISONING 4 0.0003
412 DISTURBANCE IN ATTENTION 17 0.0003
413 HEPATOTOXICITY 7 0.0003
414 VOMITING 147 0.0003
415 ENTERITIS 2 0.0003
416 SEROTONIN SYNDROME 6 0.0003
417 SINUSITIS 32 0.0003
418 PROCTALGIA 2 0.0003
419 ATELECTASIS 3 0.0003
420 ANOREXIA 4 0.0003
421 DYSTONIA 6 0.0003
422 AUTOIMMUNE DISORDER 3 0.0003
423 EPISTAXIS 23 0.0003
424 PLATELET COUNT INCREASED 4 0.0003
425 REFUSAL OF TREATMENT BY PATIENT 2 0.0003
426 COELIAC DISEASE 3 0.0003
427 ASPERGILLUS INFECTION 2 0.0003
428 CRYING 11 0.0003
429 PANIC ATTACK 11 0.0003
430 BLOOD PRESSURE ABNORMAL 6 0.0003
431 APPETITE DISORDER 2 0.0003
432 ADVERSE REACTION 4 0.0003
433 HYPOAESTHESIA 45 0.0003
434 HYPOTONIA 3 0.0003
435 VIRAL INFECTION 10 0.0003
436 FLATULENCE 17 0.0003
437 SKIN MASS 2 0.0003
438 DYSURIA 11 0.0003
439 DISEASE RECURRENCE 14 0.0003
440 GINGIVAL BLEEDING 4 0.0003
441 BLOOD TESTOSTERONE DECREASED 2 0.0003
442 RIB FRACTURE 6 0.0003
443 TEMPERATURE INTOLERANCE 3 0.0003
444 NAUSEA 230 0.0003
445 JOINT EFFUSION 2 0.0003
446 SYNCOPE 29 0.0003
447 NIGHTMARE 10 0.0003
448 LARGE INTESTINE PERFORATION 2 0.0003
449 FORMICATION 2 0.0003
450 GAIT DISTURBANCE 55 0.0003
451 WHEEZING 17 0.0003
452 SPEECH DISORDER 15 0.0003
453 RASH MACULAR 10 0.0003
454 INCONTINENCE 3 0.0003
455 CHEST DISCOMFORT 29 0.0003
456 TINNITUS 13 0.0003
457 DIVERTICULUM 2 0.0003
458 RETINAL HAEMORRHAGE 2 0.0003
459 HEADACHE 176 0.0003
460 BRONCHOSPASM 4 0.0003
461 MOVEMENT DISORDER 9 0.0003
462 PRODUCT SUPPLY ISSUE 2 0.0003
463 CONVULSION 16 0.0003
464 INFLUENZA 31 0.0003
465 APPARENT DEATH 1 0.0003
466 PANIC REACTION 2 0.0003
467 CHRONIC GRAFT VERSUS HOST DISEASE 1 0.0003
468 VISUAL FIELD DEFECT 2 0.0003
469 OESOPHAGITIS 3 0.0003
470 END STAGE RENAL DISEASE 5 0.0003
471 ILLNESS 28 0.0003
472 DENTAL CARIES 3 0.0003
473 ALCOHOL USE 1 0.0003
474 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
475 MALNUTRITION 3 0.0003
476 SNEEZING 6 0.0003
477 OXYGEN SATURATION DECREASED 15 0.0003
478 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 9 0.0003
479 CONDITION AGGRAVATED 81 0.0003
480 BLOOD SODIUM DECREASED 5 0.0003
481 PAROSMIA 2 0.0003
482 OSTEOPENIA 4 0.0003
483 GASTRIC ULCER 5 0.0003
484 DEHYDRATION 35 0.0003
485 GASTRIC DISORDER 9 0.0003
486 MUSCLE TWITCHING 6 0.0003
487 UNDERDOSE 19 0.0003
488 AGGRESSION 13 0.0003
489 MUSCULOSKELETAL CHEST PAIN 4 0.0003
490 ANKLE FRACTURE 4 0.0003
491 CONCUSSION 2 0.0003
492 DRUG SCREEN POSITIVE 2 0.0003
493 NASAL DISCOMFORT 2 0.0003
494 RENAL CYST 2 0.0003
495 HALLUCINATION, AUDITORY 4 0.0003
496 TRICUSPID VALVE INCOMPETENCE 2 0.0003
497 OBESITY 4 0.0003
498 ATRIAL FLUTTER 2 0.0003
499 NECK PAIN 14 0.0003
500 PNEUMONIA 81 0.0002
501 PRODUCT USE IN UNAPPROVED INDICATION 62 0.0002
502 MIOSIS 2 0.0002
503 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13 0.0002
504 OROPHARYNGEAL PAIN 23 0.0002
505 TASTE DISORDER 5 0.0002
506 VERTIGO 15 0.0002
507 BACK DISORDER 4 0.0002
508 AMNESIA 16 0.0002
509 DISCOMFORT 15 0.0002
510 INTENTIONAL DOSE OMISSION 7 0.0002
511 THERAPEUTIC RESPONSE UNEXPECTED 11 0.0002
512 SMALL INTESTINAL OBSTRUCTION 3 0.0002
513 ARTHRITIS BACTERIAL 1 0.0002
514 UPPER-AIRWAY COUGH SYNDROME 2 0.0002
515 BURNING SENSATION 17 0.0002
516 SPINAL COMPRESSION FRACTURE 2 0.0002
517 TOOTH EXTRACTION 3 0.0002
518 GAIT INABILITY 8 0.0002
519 DYSPNOEA 135 0.0002
520 DRUG USE DISORDER 2 0.0002
521 SENSATION OF FOREIGN BODY 2 0.0002
522 DECREASED APPETITE 55 0.0002
523 MUSCLE ATROPHY 3 0.0002
524 AORTIC VALVE INCOMPETENCE 1 0.0002
525 HYPOPHAGIA 6 0.0002
526 ALCOHOLISM 1 0.0002
527 IRRITABILITY 14 0.0002
528 INFUSION SITE PAIN 3 0.0002
529 ABNORMAL SENSATION IN EYE 1 0.0002
530 ANURIA 2 0.0002
531 APHASIA 7 0.0002
532 BLOOD MAGNESIUM DECREASED 2 0.0002
533 PRURITUS GENERALISED 5 0.0002
534 HYSTERECTOMY 2 0.0002
535 DELIRIUM 8 0.0002
536 CHAPPED LIPS 1 0.0002
537 BLOOD CALCIUM INCREASED 2 0.0002
538 ORAL CANDIDIASIS 3 0.0002
539 IMMUNE SYSTEM DISORDER 3 0.0002
540 SARS-COV-2 TEST POSITIVE 3 0.0002
541 EMOTIONAL DISORDER 7 0.0002
542 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 2 0.0002
543 CATHETERISATION CARDIAC 1 0.0002
544 TOOTH DISORDER 5 0.0002
545 WRONG DRUG ADMINISTERED 2 0.0002
546 QUALITY OF LIFE DECREASED 3 0.0002
547 BLOOD GLUCOSE INCREASED 42 0.0002
548 ANAL INCONTINENCE 2 0.0002
549 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 45 0.0002
550 TACHYPNOEA 3 0.0002
551 LIP DRY 2 0.0002
552 BLOOD PRESSURE SYSTOLIC DECREASED 1 0.0002
553 BONE DISORDER 4 0.0002
554 ABDOMINAL HERNIA 1 0.0002
555 PERIPHERAL COLDNESS 3 0.0002
556 PRODUCT USE ISSUE 41 0.0002
557 NEPHROLITHIASIS 10 0.0002
558 BUNDLE BRANCH BLOCK RIGHT 1 0.0002
559 RESPIRATORY ARREST 6 0.0002
560 RETINAL DETACHMENT 2 0.0002
561 BLOOD CHOLESTEROL ABNORMAL 1 0.0002
562 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
563 POLLAKIURIA 9 0.0002
564 ATRIAL FIBRILLATION 21 0.0002
565 PRODUCT DISTRIBUTION ISSUE 2 0.0002
566 COORDINATION ABNORMAL 3 0.0002
567 SWELLING FACE 14 0.0002
568 HOT FLUSH 16 0.0002
569 LEUKAEMIA 2 0.0002
570 SINUS TACHYCARDIA 3 0.0002
571 SPINAL DISORDER 2 0.0002
572 FOOT FRACTURE 4 0.0002
573 ASTHENIA 79 0.0002
574 RED BLOOD CELL COUNT DECREASED 6 0.0002
575 DIZZINESS POSTURAL 2 0.0002
576 EAR PAIN 4 0.0002
577 NEURALGIA 5 0.0002
578 BLOOD PRESSURE SYSTOLIC INCREASED 4 0.0002
579 PHARYNGEAL SWELLING 2 0.0002
580 RENAL TUBULAR NECROSIS 2 0.0002
581 HEPATOMEGALY 2 0.0002
582 VITREOUS FLOATERS 2 0.0002
583 DYSPEPSIA 20 0.0002
584 BODY TEMPERATURE DECREASED 2 0.0002
585 PSYCHOTIC DISORDER 6 0.0002
586 BREATH SOUNDS ABNORMAL 1 0.0002
587 HOSPICE CARE 2 0.0002
588 DRUG EFFECT LESS THAN EXPECTED 3 0.0002
589 SKIN HAEMORRHAGE 3 0.0002
590 ABASIA 5 0.0002
591 DISABILITY 4 0.0002
592 DYSGEUSIA 15 0.0002
593 CONSTIPATION 44 0.0002
594 VISUAL IMPAIRMENT 25 0.0002
595 ANEURYSM 1 0.0002
596 UPPER LIMB FRACTURE 4 0.0002
597 THERAPY NON-RESPONDER 9 0.0002
598 DYSPHAGIA 19 0.0002
599 BRAIN INJURY 2 0.0002
600 HYPERTENSION 42 0.0002
601 EMPHYSEMA 2 0.0002
602 ECONOMIC PROBLEM 3 0.0002
603 BLOOD COUNT ABNORMAL 3 0.0002
604 PARAESTHESIA 31 0.0002
605 EYELID PTOSIS 2 0.0002
606 TOOTH ABSCESS 2 0.0002
607 SLUGGISHNESS 2 0.0002
608 AMMONIA INCREASED 1 0.0002
609 EAR DISCOMFORT 2 0.0002
610 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
611 CACHEXIA 1 0.0002
612 CEREBRAL ISCHAEMIA 1 0.0002
613 INTENTIONAL PRODUCT MISUSE 17 0.0002
614 LIMB DISCOMFORT 6 0.0002
615 RASH GENERALISED 5 0.0002
616 HYPERBILIRUBINAEMIA 2 0.0002
617 VENTRICULAR EXTRASYSTOLES 2 0.0002
618 TENDERNESS 2 0.0002
619 ROAD TRAFFIC ACCIDENT 8 0.0002
620 WEIGHT FLUCTUATION 2 0.0002
621 PRODUCT ODOUR ABNORMAL 2 0.0002
622 SEDATION 5 0.0002
623 CATATONIA 1 0.0002
624 GASTRITIS 5 0.0002
625 ADVERSE DRUG REACTION 17 0.0002
626 JOINT DISLOCATION 2 0.0002
627 PNEUMOTHORAX 3 0.0002
628 CHEST PAIN 35 0.0002
629 ANORECTAL DISCOMFORT 1 0.0002
630 EATING DISORDER 4 0.0002
631 BREAST PAIN 2 0.0002
632 JOINT INJURY 4 0.0002
633 IMPAIRED WORK ABILITY 4 0.0002
634 BRUXISM 1 0.0002
635 MUSCLE TIGHTNESS 3 0.0002
636 BEHAVIOUR DISORDER 1 0.0002
637 LIMB INJURY 5 0.0002
638 INCORRECT DOSE ADMINISTERED 42 0.0002
639 SKIN LACERATION 2 0.0002
640 BACK INJURY 2 0.0002
641 LUNG DISORDER 9 0.0002
642 PNEUMONITIS 5 0.0002
643 PULMONARY THROMBOSIS 2 0.0002
644 ASPIRATION 2 0.0002
645 MALAISE 80 0.0002
646 FATIGUE 142 0.0002
647 ASTHENOPIA 1 0.0002
648 AUTISM SPECTRUM DISORDER 1 0.0002
649 BLOOD PRESSURE DECREASED 12 0.0002
650 FOOT DEFORMITY 2 0.0002
651 DRY EYE 9 0.0002
652 FUNGAL INFECTION 6 0.0002
653 ARTHROPATHY 10 0.0002
654 MUSCLE SPASMS 33 0.0002
655 PULMONARY OEDEMA 8 0.0002
656 ORAL PAIN 4 0.0002
657 CELLULITIS 9 0.0002
658 ANGIOPATHY 1 0.0002
659 SKIN INFECTION 2 0.0002
660 CANDIDA INFECTION 3 0.0002
661 ANGER 6 0.0002
662 DERMATITIS CONTACT 2 0.0002
663 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
664 SCAR 3 0.0002
665 INTERNAL HAEMORRHAGE 2 0.0002
666 CARDIAC VALVE DISEASE 1 0.0002
667 LOCAL SWELLING 3 0.0002
668 COVID-19 30 0.0002
669 CHILLS 20 0.0002
670 SEXUAL DYSFUNCTION 2 0.0002
671 OCULAR HYPERAEMIA 8 0.0002
672 CATARACT OPERATION 1 0.0002
673 GALLBLADDER DISORDER 3 0.0002
674 MYOCLONUS 2 0.0002
675 BLOOD POTASSIUM DECREASED 5 0.0002
676 CONTUSION 16 0.0002
677 DRUG EFFECT INCOMPLETE 6 0.0002
678 PELVIC PAIN 3 0.0002
679 CORONARY ARTERY DISEASE 5 0.0002
680 FIBROMYALGIA 4 0.0002
681 URINARY TRACT INFECTION 28 0.0002
682 ENCEPHALOPATHY 4 0.0002
683 GASTROOESOPHAGEAL REFLUX DISEASE 13 0.0002
684 PRURITUS 62 0.0002
685 BLOOD ALKALINE PHOSPHATASE INCREASED 4 0.0002
686 MIDDLE INSOMNIA 3 0.0002
687 PNEUMONIA ASPIRATION 4 0.0002
688 INTENTIONAL PRODUCT USE ISSUE 14 0.0002
689 BLEPHAROSPASM 1 0.0002
690 HEAD INJURY 5 0.0002
691 CHRONIC KIDNEY DISEASE 12 0.0002
692 TACHYCARDIA 14 0.0002
693 FLUSHING 16 0.0002
694 HYPOTHYROIDISM 5 0.0002
695 INJURY 11 0.0002
696 PYREXIA 54 0.0002
697 ANGINA UNSTABLE 1 0.0002
698 DEPRESSION 35 0.0002
699 ORAL HERPES 3 0.0002
700 PRODUCT DOSE OMISSION 10 0.0002
701 TOOTH INFECTION 2 0.0002
702 ACTIVITIES OF DAILY LIVING IMPAIRED 3 0.0002
703 RASH 66 0.0002
704 VISUAL ACUITY REDUCED 5 0.0002
705 EAR INFECTION 4 0.0002
706 SKIN DISORDER 5 0.0001
707 EYE HAEMORRHAGE 2 0.0001
708 SPINAL FRACTURE 3 0.0001
709 FEAR 4 0.0001
710 PRODUCT PHYSICAL ISSUE 3 0.0001
711 PRODUCT ADMINISTRATION ERROR 3 0.0001
712 FREQUENT BOWEL MOVEMENTS 4 0.0001
713 BODY TEMPERATURE INCREASED 3 0.0001
714 DRUG TOXICITY 2 0.0001
715 ABNORMAL LOSS OF WEIGHT 1 0.0001
716 ERYTHEMA 30 0.0001
717 OSTEOPOROSIS 6 0.0001
718 CORONARY ARTERY OCCLUSION 2 0.0001
719 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 7 0.0001
720 GASTROINTESTINAL DISORDER 13 0.0001
721 DIVERTICULITIS 4 0.0001
722 HUNGER 2 0.0001
723 WOUND 4 0.0001
724 CARPAL TUNNEL SYNDROME 2 0.0001
725 PERIPHERAL SWELLING 22 0.0001
726 HEART RATE DECREASED 5 0.0001
727 SLEEP DISORDER 10 0.0001
728 PRODUCT DOSE OMISSION IN ERROR 4 0.0001
729 SUBDURAL HAEMATOMA 2 0.0001
730 RECTAL HAEMORRHAGE 6 0.0001
731 IMPAIRED QUALITY OF LIFE 2 0.0001
732 DRUG INTERACTION 22 0.0001
733 ALTERED STATE OF CONSCIOUSNESS 3 0.0001
734 FALL 46 0.0001
735 MENTAL DISORDER 6 0.0001
736 HYPOKINESIA 2 0.0001
737 FLUID RETENTION 7 0.0001
738 CLOSTRIDIUM DIFFICILE INFECTION 3 0.0001
739 ACCIDENTAL EXPOSURE TO PRODUCT 14 0.0001
740 LABORATORY TEST ABNORMAL 4 0.0001
741 CEREBRAL DISORDER 1 0.0001
742 ARTHROPOD BITE 1 0.0001
743 RASH MACULO-PAPULAR 3 0.0001
744 PULMONARY MASS 2 0.0001
745 GLOSSODYNIA 3 0.0001
746 HAEMORRHAGE INTRACRANIAL 2 0.0001
747 RESPIRATORY DISORDER 4 0.0001
748 MUSCULOSKELETAL PAIN 7 0.0001
749 WEIGHT DECREASED 37 0.0001
750 PRODUCT QUALITY ISSUE 18 0.0001
751 LACRIMATION INCREASED 4 0.0001
752 COLITIS 5 0.0001
753 PLEURAL EFFUSION 8 0.0001
754 AORTIC ANEURYSM 1 0.0001
755 OEDEMA PERIPHERAL 16 0.0001
756 ACIDOSIS 1 0.0001
757 HIP ARTHROPLASTY 2 0.0001
758 BOWEL MOVEMENT IRREGULARITY 1 0.0001
759 DRUG ADMINISTRATION ERROR 4 0.0001
760 PALMAR-PLANTAR ERYTHRODYSAESTHESIA SYNDROME 3 0.0001
761 EJECTION FRACTION DECREASED 2 0.0001
762 COGNITIVE DISORDER 6 0.0001
763 APNOEA 1 0.0001
764 RENAL FAILURE 17 0.0001
765 ARTERIAL OCCLUSIVE DISEASE 1 0.0001
766 HAEMATOCHEZIA 7 0.0001
767 PULMONARY EMBOLISM 12 0.0001
768 BLOOD ALBUMIN DECREASED 1 0.0001
769 MEDICATION ERROR 7 0.0001
770 CYSTITIS 4 0.0001
771 MUSCULOSKELETAL STIFFNESS 11 0.0001
772 MOOD SWINGS 4 0.0001
773 SCIATICA 2 0.0001
774 ABSCESS 2 0.0001
775 PANCYTOPENIA 7 0.0001
776 BLOOD DISORDER 1 0.0001
777 ABDOMINAL PAIN 29 0.0001
778 SENSORY DISTURBANCE 2 0.0001
779 NIGHT SWEATS 4 0.0001
780 LOCALISED INFECTION 3 0.0001
781 ASTHMA 14 0.0001
782 ASPHYXIA 1 0.0001
783 PHOTOSENSITIVITY REACTION 2 0.0001
784 COAGULOPATHY 2 0.0001
785 HYPOTENSION 24 0.0001
786 BLOOD UREA INCREASED 2 0.0001
787 SURGERY 7 0.0001
788 EYE PRURITUS 4 0.0001
789 TRANSIENT ISCHAEMIC ATTACK 4 0.0001
790 RENAL FAILURE ACUTE 5 0.0001
791 SWELLING 11 0.0001
792 INFECTION 17 0.0001
793 ERECTILE DYSFUNCTION 3 0.0001
794 MEMORY IMPAIRMENT 16 0.0001
795 BACK PAIN 27 0.0001
796 JOINT SWELLING 14 0.0001
797 HAEMATOMA 3 0.0001
798 NEUROPATHY PERIPHERAL 11 0.0001
799 CARDIAC MURMUR 1 0.0001
800 PHARMACEUTICAL PRODUCT COMPLAINT 3 0.0001
801 MUSCULAR WEAKNESS 13 0.0001
802 JOINT STIFFNESS 3 0.0001
803 NEUROTOXICITY 2 0.0001
804 AMENORRHOEA 2 0.0001
805 PANCREATITIS 6 0.0001
806 PLATELET COUNT DECREASED 12 0.0001
807 ISCHAEMIC STROKE 2 0.0001
808 CARDIAC FAILURE CONGESTIVE 9 0.0001
809 THIRST 2 0.0001
810 JAUNDICE 3 0.0001
811 DISEASE PROGRESSION 13 0.0001
812 PAIN 67 0.0001
813 SKIN DISCOLOURATION 5 0.0001
814 BLOOD THYROID STIMULATING HORMONE INCREASED 1 0.0001
815 ANAPHYLACTIC REACTION 6 0.0001
816 BLOOD GLUCOSE ABNORMAL 2 0.0001
817 BREAST CANCER STAGE I 1 0.0001
818 HEPATIC STEATOSIS 2 0.0001
819 DEMENTIA 3 0.0001
820 RENAL DISORDER 5 0.0001
821 THROMBOCYTOPENIA 12 0.0001
822 BACTERIAL INFECTION 2 0.0001
823 CARDIAC DISORDER 10 0.0001
824 TARDIVE DYSKINESIA 3 0.0001
825 PAIN IN JAW 3 0.0001
826 BLOOD URINE PRESENT 2 0.0001
827 HYPERSOMNIA 3 0.0001
828 RASH ERYTHEMATOUS 5 0.0001
829 WHITE BLOOD CELL COUNT INCREASED 4 0.0001
830 BLOOD GLUCOSE DECREASED 5 0.0001
831 LOWER LIMB FRACTURE 2 0.0001
832 ACUTE RESPIRATORY FAILURE 2 0.0001
833 AFFECT LABILITY 1 0.0001
834 HAEMORRHOIDS 2 0.0001
835 KIDNEY INFECTION 2 0.0001
836 WHITE BLOOD CELL COUNT DECREASED 11 0.0001
837 HAEMATOCRIT DECREASED 2 0.0001
838 BLADDER DISORDER 1 0.0001
839 CARDIAC FAILURE 8 0.0001
840 FULL BLOOD COUNT DECREASED 2 0.0001
841 EMOTIONAL DISTRESS 12 0.0001
842 INTENTIONAL SELF-INJURY 2 0.0001
843 ARTHRALGIA 41 0.0001
844 PRODUCT PREPARATION ERROR 2 0.0001
845 PERITONITIS 2 0.0001
846 DRUG-INDUCED LIVER INJURY 3 0.0001
847 SEIZURE 11 0.0001
848 TOXICITY TO VARIOUS AGENTS 16 0.0001
849 WEIGHT INCREASED 21 0.0001
850 HIP FRACTURE 3 0.0001
851 IRRITABLE BOWEL SYNDROME 2 0.0001
852 LIVER FUNCTION TEST INCREASED 2 0.0001
853 HYPOACUSIS 4 0.0001
854 SKIN CANCER 2 0.0001
855 DEEP VEIN THROMBOSIS 6 0.0001
856 PRODUCT DISPENSING ERROR 2 0.0001
857 DIABETES MELLITUS 7 0.0001
858 CHOLELITHIASIS 3 0.0001
859 NEOPLASM MALIGNANT 6 0.0001
860 SEPSIS 10 0.0001
861 ANAEMIA 17 0.0001
862 BLISTER 5 0.0001
863 EYE PAIN 5 0.0001
864 CEREBROVASCULAR ACCIDENT 15 0.0001
865 CHOLECYSTECTOMY 1 0.0001
866 SUICIDAL IDEATION 8 0.0001
867 EYE IRRITATION 5 0.0001
868 DEVICE USE ERROR 3 0.0001
869 ABDOMINAL DISTENSION 9 0.0001
870 BLOOD CHOLESTEROL INCREASED 4 0.0001
871 HOSPITALISATION 13 0.0001
872 ARRHYTHMIA 4 0.0001
873 PRODUCT PRESCRIBING ERROR 2 0.0001
874 CATARACT 5 0.0001
875 ACCIDENT 1 0.0001
876 MOBILITY DECREASED 6 0.0001
877 SKIN EXFOLIATION 7 0.0001
878 WRONG TECHNIQUE IN DRUG USAGE PROCESS 3 0.0001
879 MENTAL IMPAIRMENT 2 0.0001
880 ADRENAL INSUFFICIENCY 1 0.0001
881 MYALGIA 14 0.0001
882 HYPERGLYCAEMIA 3 0.0001
883 RESPIRATORY FAILURE 6 0.0001
884 EXTRAPYRAMIDAL DISORDER 2 0.0001
885 INTESTINAL OBSTRUCTION 3 0.0001
886 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
887 INJECTION SITE SWELLING 6 0.0001
888 HEPATITIS 2 0.0001
889 PLASMA CELL MYELOMA 3 0.0001
890 INCORRECT DOSE ADMINISTERED BY DEVICE 2 0.0001
891 ANHEDONIA 2 0.0001
892 BEDRIDDEN 1 0.0001
893 DEPRESSED MOOD 4 0.0001
894 INFUSION RELATED REACTION 5 0.0001
895 PRODUCT DOSE OMISSION ISSUE 22 0.0001
896 PAIN OF SKIN 2 0.0001
897 BLOOD BILIRUBIN INCREASED 2 0.0001
898 RASH PRURITIC 4 0.0001
899 BLINDNESS 3 0.0001
900 MOOD ALTERED 2 0.0001
901 MIGRAINE 7 0.0001
902 INFLUENZA LIKE ILLNESS 6 0.0001
903 PROCEDURAL PAIN 2 0.0001
904 BLOOD TEST ABNORMAL 1 0.0001
905 OSTEOARTHRITIS 3 0.0001
906 CARDIOGENIC SHOCK 1 0.0001
907 PRODUCT SUBSTITUTION ISSUE 4 0.0001
908 SEPTIC SHOCK 3 0.0001
909 LIVER FUNCTION TEST ABNORMAL 2 0.0001
910 BONE PAIN 4 0.0001
911 DRY SKIN 9 0.0001
912 ACUTE KIDNEY INJURY 10 0.0001
913 INJECTION SITE RASH 2 0.0001
914 FEMUR FRACTURE 2 0.0001
915 PAIN IN EXTREMITY 19 0.0001
916 BASAL CELL CARCINOMA 1 0.0001
917 NERVOUS SYSTEM DISORDER 2 0.0001
918 OFF LABEL USE 55 0.0001
919 INTERSTITIAL LUNG DISEASE 3 0.0001
920 BLOOD POTASSIUM INCREASED 1 0.0001
921 BLOOD CREATININE INCREASED 4 0.0001
922 THERAPEUTIC RESPONSE SHORTENED 2 0.0001
923 FEBRILE NEUTROPENIA 4 0.0001
924 TYPE 2 DIABETES MELLITUS 2 0.0001
925 HEPATIC ENZYME INCREASED 4 0.0001
926 THERAPY CESSATION 3 0.0001
927 INFLAMMATION 3 0.0001
928 HAEMORRHAGE 6 0.0001
929 BLOOD TRIGLYCERIDES INCREASED 1 0.0001
930 ACUTE RESPIRATORY DISTRESS SYNDROME 1 0.0001
931 SYSTEMIC LUPUS ERYTHEMATOSUS 2 0.0001
932 DRUG DEPENDENCE 9 0.0001
933 OEDEMA 3 0.0001
934 TREATMENT NONCOMPLIANCE 3 0.0001
935 DEPENDENCE 3 0.0001
936 AGRANULOCYTOSIS 1 0.0001
937 HERPES ZOSTER 3 0.0001
938 MYOCARDIAL INFARCTION 9 0.0001
939 NEUTROPENIA 7 0.0001
940 ARTHRITIS 4 0.0001
941 THROMBOSIS 4 0.0000
942 SUICIDE ATTEMPT 3 0.0000
943 ILL-DEFINED DISORDER 3 0.0000
944 ALANINE AMINOTRANSFERASE INCREASED 3 0.0000
945 HAEMOGLOBIN DECREASED 5 0.0000
946 CARDIAC ARREST 4 0.0000
947 INJECTION SITE ERYTHEMA 6 0.0000
948 EXPOSURE DURING PREGNANCY 3 0.0000
949 APPLICATION SITE PAIN 1 0.0000
950 ANGIOEDEMA 2 0.0000
951 LIVER DISORDER 2 0.0000
952 DEVICE ISSUE 4 0.0000
953 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
954 SKIN IRRITATION 2 0.0000
955 INJECTION SITE REACTION 3 0.0000
956 ADVERSE EVENT 4 0.0000
957 HYPOKALAEMIA 2 0.0000
958 COMA 2 0.0000
959 THERAPY INTERRUPTED 3 0.0000
960 SKIN BURNING SENSATION 3 0.0000
961 MULTIPLE SCLEROSIS 2 0.0000
962 BLOOD PRESSURE FLUCTUATION 1 0.0000
963 DRUG INTOLERANCE 4 0.0000
964 ACNE 3 0.0000
965 INJECTION SITE PAIN 12 0.0000
966 ANAPHYLACTIC SHOCK 1 0.0000
967 DEATH 33 0.0000
968 BRADYCARDIA 2 0.0000
969 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
970 DRUG EFFECT DECREASED 2 0.0000
971 HYPONATRAEMIA 2 0.0000
972 RHEUMATOID ARTHRITIS 4 0.0000
973 ANGINA PECTORIS 1 0.0000
974 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
975 GENERAL PHYSICAL HEALTH DETERIORATION 4 0.0000
976 PRODUCT STORAGE ERROR 3 0.0000
977 ASCITES 1 0.0000
978 ACUTE MYOCARDIAL INFARCTION 1 0.0000
979 STOMATITIS 2 0.0000
980 ALOPECIA 6 0.0000
981 INJECTION SITE PRURITUS 2 0.0000
982 MALIGNANT NEOPLASM PROGRESSION 3 0.0000
983 MULTIPLE SCLEROSIS RELAPSE 2 0.0000
984 DEVICE MALFUNCTION 2 0.0000
985 CEREBRAL HAEMORRHAGE 1 0.0000
986 DRUG DOSE OMISSION BY DEVICE 2 0.0000
987 INJECTION SITE BRUISING 2 0.0000
988 DRUG DOSE OMISSION 4 0.0000
989 COMPLETED SUICIDE 2 0.0000
990 CARDIO-RESPIRATORY ARREST 1 0.0000
991 RENAL IMPAIRMENT 2 0.0000
992 PSORIASIS 2 0.0000